Polyarticular juvenile idiopathic arthritisNews & Research

6 curated articles for Polyarticular juvenile idiopathic arthritis — FDA updates, peer-reviewed research, clinical-trial milestones, and sponsor press releases. Sorted newest-first.

ℹ
UniteRare data is compiled from authoritative primary sources (FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, NORD), then processed through automated and AI-assisted extraction pipelines.
Report missing data
  1. Biologicals : journal of the International Association of Biological Standardization May 9, 2026

    Status and progress in the development of rDNA-derived Tocilizumab and its biosimilars for treatment of rheumatoid arthritis.

    The immune system unintentionally targets the synovial lining of the joints in rheumatoid arthritis (RA), a chronic autoimmune disease that causes inflammation, discomfort, and gradual joint destruction. A humanized anti-IL-6R monoclonal antibody (mAb), tocilizumab (TCZ) is primarily used to treat r...

    Why it matters: Recent peer-reviewed research on Polyarticular juvenile idiopathic arthritis that may be relevant for patients and caregivers.

  2. BMC pediatrics May 7, 2026

    Correction: Comparative efficacy and safety of etanercept and adalimumab in the treatment of polyarticular juvenile idiopathic arthritis.

    Correction: Comparative efficacy and safety of etanercept and adalimumab in the treatment of polyarticular juvenile idiopathic arthritis.

    Why it matters: Recent peer-reviewed research on Polyarticular juvenile idiopathic arthritis that may be relevant for patients and caregivers.

  3. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences May 6, 2026

    [Clinical characteristics and outcomes of children with rheu-matoid factor-positive polyarticular juvenile idiopathic arthritis].

    To compare the clinical characteristics and outcomes between patients with rheumatoid factor (RF)-positive and RF-negative polyarticular juvenile idiopathic arthritis (pJIA). A retrospective analysis was conducted on clinical data of 131 children diagnosed with pJIA at the Children's Hospital, Zheji...

    Why it matters: Recent peer-reviewed research on Polyarticular juvenile idiopathic arthritis that may be relevant for patients and caregivers.

  4. International journal of rheumatic diseases Apr 25, 2026

    Drug-Induced Subacute Cutaneous Lupus Erythematosus Under Adalimumab in a Child With Polyarticular Juvenile Idiopathic Arthritis: IFN-α and TNF-α-Skewed Cytokine Profile.

    Drug-Induced Subacute Cutaneous Lupus Erythematosus Under Adalimumab in a Child With Polyarticular Juvenile Idiopathic Arthritis: IFN-α and TNF-α-Skewed Cytokine Profile.

    Why it matters: Recent peer-reviewed research on Polyarticular juvenile idiopathic arthritis that may be relevant for patients and caregivers.

  5. Cureus Mar 26, 2026

    A Case of Refractory Polyarticular Juvenile Idiopathic Arthritis Post-hematopoietic Stem Cell Transplantation Successfully Treated With Ruxolitinib.

    Allogeneic hematopoietic stem cell transplantation (allo-HSCT) may trigger secondary autoimmune diseases, with autoimmune arthritis representing a rare yet challenging complication. Here, we report a six-year-old male who developed polyarticular juvenile idiopathic arthritis (JIA) three years after ...

    Why it matters: Recent peer-reviewed research on Polyarticular juvenile idiopathic arthritis that may be relevant for patients and caregivers.

  6. Klinische Padiatrie Mar 4, 2026

    Camptodactyly-Arthropathy-Coxa Vara-Pericarditis Syndrome without Camptodactyly: A Pediatric Case and Review of the Literature.

    Camptodactyly-arthropathy-coxa vara-pericarditis syndrome is a rare autosomal recessive disorder with camptodactyly, non-inflammatory arthropathy, coxa vara, and pericarditis. Symptoms usually begin in early childhood with swelling of interphalangeal joints, wrists, and knees. Pericarditis is rare. ...

    Why it matters: Recent peer-reviewed research on Polyarticular juvenile idiopathic arthritis that may be relevant for patients and caregivers.

More on Polyarticular juvenile idiopathic arthritis

Articles aggregated from peer-reviewed journals (PubMed), sponsor press releases, SEC 8-K filings, and FDA announcements. Original-source links are preserved on each article page. Editorial tags (Breaking / Notable / Update) reflect UniteRare's curation-time priority assessment.